Rossari Biotech Limited

BSE: 543213 NSE: ROSSARI
Rossari Biotech Limited - chemicals and materials in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L24100MH2009PLC194818 Incorporated 10 August 2009 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: ROSSARI · BSE: 543213 Public Limited Company chemicals and materials
Data last updated
Revenue · FY 2026
₹2,396.37 Cr
▲ 15.19% YoY
EBITDA · FY 2026
₹308.28 Cr
▲ 14.56% YoY
Net profit · FY 2026
₹149.21 Cr
▲ 9.41% YoY
Authorised capital
₹12 Cr
Registered with MCA
Paid-up capital
₹11.08 Cr
Issued & subscribed
Open charges
₹275.22 Cr
Satisfied ₹110.54 Cr
Company age
17 yrs
Est. 2009
Employees · EPFO
459
Latest available

About Rossari Biotech Limited

Data last updated: 23 December 2025

Rossari Biotech Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in specialty chemicals, a part of the broader chemicals and materials sector. Incorporated on 10 August 2009, the company has been in operation for over 17 years.

Registered with ROC Mumbai under CIN L24100MH2009PLC194818. Listed on BSE: 543213 and NSE: ROSSARI.

Capital: an authorised share capital of ₹12 Cr and a paid-up capital of ₹11.08 Cr. It is led by directors including Esha Padmanabhan Achan and Ketan Sablok.

Last AGM: 30 June 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹2,084.3 Cr, a growth of 13% compared to the previous year.

The company has a workforce of approximately 459 employees as per the latest available data. Its group structure includes 5 subsidiaries.

The company is associated with 2 brands - Rossari Biotech, Unitop Chemicals. As per MCA filings, the company has open charges of ₹275.22 Cr and satisfied charges of ₹110.54 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rossari.com.

Company Details of Rossari Biotech Limited
CIN L24100MH2009PLC194818
Registration Number 194818
Incorporation Date 10 August 2009
ROC Mumbai
Listing Status Listed (BSE: 543213, NSE: ROSSARI)
Company Status Active
Date of Last AGM 30 June 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Sunil Srinivasan Chari Managing Director Edward Walter Menezes Whole-Time Director Ketan Sablok Cfo
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    rossari.com
  • Social Media
  • Registered Address
    Rossari House Golden Oak Lbs Marg Surya Nagar, Opp. Mahindra Showroom Vikhroli (West), Mumbai, Maharashtra, India – 400079
  • Industry
    Chemicals and Materials, Specialty Chemicals
Company report
Rossari Biotech Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Rossari Biotech Limited report

Financials, compliance, directors, charges, ownership and filings for Rossari Biotech Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Rossari Biotech Limited

Rossari Biotech Limited has one previous CIN (Corporate Identification Number): U24100MH2009PLC194818. The current CIN is L24100MH2009PLC194818, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24100MH2009PLC194818 Current
U24100MH2009PLC194818 Previous

Associated Brands with Rossari Biotech Limited

Rossari Biotech Limited operates two associated brands: Rossari Biotech and Unitop Chemicals. These brands represent Rossari Biotech Limited's diversified market presence and brand portfolio.

Brand Description Website
Rossari Biotech
Manufacturer of textile and specialty chemicals for diverse industries and animal health nutrition products rossari.com
Unitop Chemicals
Surfactants and emulsifiers are manufactured for industrial applications. unitopchemicals.com

Business Activity of Rossari Biotech Limited

Rossari Biotech Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Rossari Biotech Limited

Rossari Biotech Limited is audited by Walker Chandiok & Co LLP (ICAI peer reviewed, certificate valid till 2028-05-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Walker Chandiok & Co LLP (ICAI peer reviewed, certificate valid till 2028-05-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Rossari Biotech Limited

Rossari Biotech Limited is currently managed by 8 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Esha Padmanabhan Achan
Also directs: Man Industries (India) Limited, Meganet Technologies Global Limited
Director 21 Oct 2023 2 Years 8 Months Current
Ketan Sablok
Also directs: Romakk Chemicals Private Limited
Cfo 01 May 2023 3 Years 2 Months Current
Sunil Srinivasan Chari
Also directs: Sunjyot Properties Llp, Rossari Biotech (India) Private Limited, Unitop Chemicals Private Limited and 5 more
Managing Director 26 Sep 2019 6 Years 9 Months Current
Aseem Dhru
Also directs: Safari Industries (India) Limited, Sbfc Finance Limited, Sbfc Home Finance Private Limited
Director 12 Nov 2019 6 Years 7 Months Current
Gurudas Vishwas Aras
Also directs: Unitop Chemicals Private Limited, Tristar Intermediates Private Limited, Romakk Chemicals Private Limited and 2 more
Director 19 Oct 2024 1 Years 8 Months Current
Edward Walter Menezes
Also directs: Rossari Biotech (India) Private Limited, Unitop Chemicals Private Limited, Rossari Consumer Products Private Limited and 5 more
Whole-Time Director 10 Aug 2009 16 Years 10 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Rossari Biotech Limited FY 2026 filings available

Rossari Biotech Limited reported revenue of ₹2,396.37 Cr (up 15.19% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹2,396.37 Cr ▲ 15.19%
Profit · FY 2026
₹149.21 Cr ▲ 9.41%
EBITDA · FY 2026
₹308.28 Cr ▲ 14.56%
Revenue₹ Cr · Consolidated01,0002,0003,000FY 2021: ₹709 Cr709FY 2021FY 2022: ₹1,483 Cr · +109.1% YoY1,483+109.1%FY 2022FY 2023: ₹1,656 Cr · +11.7% YoY1,656+11.7%FY 2023FY 2024: ₹1,831 Cr · +10.5% YoY1,831+10.5%FY 2024FY 2025: ₹2,080 Cr · +13.6% YoY2,080+13.6%FY 2025FY 2026: ₹2,396 Cr · +15.2% YoY2,396+15.2%FY 2026
Net Profit₹ Cr · Consolidated050100150FY 2021: ₹80 Cr80FY 2021FY 2022: ₹98 Cr · +22% YoY97.7+22%FY 2022FY 2023: ₹107 Cr · +9.8% YoY107+9.8%FY 2023FY 2024: ₹131 Cr · +21.8% YoY131+21.8%FY 2024FY 2025: ₹136 Cr · +4.4% YoY136+4.4%FY 2025FY 2026: ₹149 Cr · +9.4% YoY149+9.4%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0250500750Q1'25: ₹490 Cr · +19.3% YoY490+19.3%Q1'25Q2'25: ₹498 Cr · +3.1% YoY498+3.1%Q2'25Q3'25: ₹513 Cr · +10.6% YoY513+10.6%Q3'25Q4'25: ₹580 Cr · +22.6% YoY580+22.6%Q4'25Q1'26: ₹544 Cr · +11% YoY544+11%Q1'26Q2'26: ₹586 Cr · +17.6% YoY586+17.6%Q2'26Q3'26: ₹582 Cr · +13.4% YoY582+13.4%Q3'26Q4'26: ₹685 Cr · +18.2% YoY685+18.2%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue from Operations ₹2,396.37 Cr ₹2,080.29 Cr ₹1,830.56 Cr ₹1,655.88 Cr ₹1,482.97 Cr ₹709.35 Cr
Other Income ₹22.38 Cr ₹4.01 Cr ₹7.45 Cr ₹5.48 Cr ₹12 Cr ₹9.19 Cr
Total Income ₹2,418.74 Cr ₹2,084.3 Cr ₹1,838 Cr ₹1,661.37 Cr ₹1,494.97 Cr ₹718.54 Cr
Cost of Materials Consumed ₹1,603.68 Cr ₹1,299.64 Cr ₹1,229.92 Cr ₹1,079.11 Cr ₹970.12 Cr ₹434.81 Cr
Purchases of Stock-in-Trade ₹93.42 Cr ₹164.77 Cr ₹127.13 Cr ₹104.85 Cr ₹155.21 Cr ₹35.81 Cr
Changes in Inventories -₹28.37 Cr -₹31.12 Cr -₹63.52 Cr -₹12.64 Cr -₹20.29 Cr -₹8.42 Cr
Employee Benefit Expense ₹154.75 Cr ₹132.33 Cr ₹103.13 Cr ₹98.62 Cr ₹67.93 Cr ₹41.98 Cr
Finance Costs ₹28.54 Cr ₹17.81 Cr ₹19.37 Cr ₹22.32 Cr ₹12.66 Cr ₹2.99 Cr
Depreciation & Amortisation ₹79.12 Cr ₹67.07 Cr ₹60.39 Cr ₹62.93 Cr ₹48.06 Cr ₹22.83 Cr
Other Expenses ₹286.99 Cr ₹249.59 Cr ₹184.15 Cr ₹162.93 Cr ₹126.56 Cr ₹82.12 Cr
Total Expenses ₹2,218.13 Cr ₹1,900.1 Cr ₹1,660.56 Cr ₹1,518.1 Cr ₹1,360.24 Cr ₹612.11 Cr
Profit Before Exceptional Items & Tax ₹200.61 Cr ₹184.21 Cr ₹177.44 Cr ₹143.26 Cr ₹134.73 Cr ₹106.43 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹200.61 Cr ₹184.21 Cr ₹177.44 Cr ₹143.26 Cr ₹134.73 Cr ₹106.43 Cr
Total Tax Expense ₹53.3 Cr ₹48.81 Cr ₹46.93 Cr ₹36.96 Cr ₹38.58 Cr ₹26.79 Cr
Net Profit ₹149.21 Cr ₹136.38 Cr ₹130.69 Cr ₹107.26 Cr ₹97.7 Cr ₹80.05 Cr
  attributable to Owners ₹149.21 Cr ₹136.38 Cr ₹130.69 Cr - ₹97.67 Cr ₹80.22 Cr
  attributable to NCI ₹0 ₹0 ₹0 - ₹2.1 Lakh -₹17.4 Lakh
Other Comprehensive Income ₹7.6 Lakh -₹1.03 Cr ₹90,000 ₹30 Lakh ₹8.5 Lakh ₹10.6 Lakh
Total Comprehensive Income ₹149.29 Cr ₹135.35 Cr ₹130.7 Cr ₹107.56 Cr ₹97.78 Cr ₹80.15 Cr
EBITDA (computed) ₹308.28 Cr ₹269.09 Cr ₹257.2 Cr ₹228.51 Cr ₹195.44 Cr ₹132.25 Cr
Basic EPS ₹26.95 ₹24.66 ₹23.67 ₹19.46 ₹17.81 ₹15.56
Diluted EPS ₹26.93 ₹24.63 ₹23.62 ₹19.38 ₹17.70 ₹15.47
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹2,288.79 Cr ₹1,896.18 Cr ₹1,572.15 Cr ₹1,367.57 Cr
Non-current Assets ₹1,045.12 Cr ₹853.05 Cr ₹727.37 Cr ₹646.41 Cr
Current Assets ₹1,235.9 Cr ₹1,041.93 Cr ₹843.58 Cr ₹721.16 Cr
Property, Plant & Equipment ₹560.54 Cr ₹353.53 Cr ₹314.69 Cr ₹313.61 Cr
Inventories ₹404.55 Cr ₹355.08 Cr ₹282.33 Cr ₹188.48 Cr
Trade Receivables ₹557.41 Cr ₹474.5 Cr ₹425.13 Cr ₹353.66 Cr
Cash & Equivalents ₹75.31 Cr ₹44.2 Cr ₹25.17 Cr ₹69.83 Cr
Equity (Net Worth) ₹1,333.35 Cr ₹1,185.45 Cr ₹1,047.73 Cr ₹915.17 Cr
Equity Share Capital ₹11.08 Cr ₹11.07 Cr ₹11.05 Cr ₹11.03 Cr
Borrowings (Non-current) ₹94.33 Cr ₹100.03 Cr ₹33.32 Cr ₹34.93 Cr
Borrowings (Current) ₹313.66 Cr ₹87.94 Cr ₹72.5 Cr ₹39 Cr
Total Debt (computed) ₹407.99 Cr ₹187.97 Cr ₹105.83 Cr ₹73.93 Cr
Current Liabilities ₹789.56 Cr ₹536.57 Cr ₹424.74 Cr ₹346.86 Cr
Total Liabilities ₹955.44 Cr ₹710.74 Cr ₹524.42 Cr ₹452.4 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹65.07 Cr ₹137.44 Cr ₹43.26 Cr ₹152.39 Cr ₹29.36 Cr
Investing Cash Flow -₹219.48 Cr -₹183.7 Cr -₹103.21 Cr -₹180.89 Cr -₹298.88 Cr
Financing Cash Flow ₹186.32 Cr ₹64.9 Cr ₹16.19 Cr ₹60.86 Cr ₹291.79 Cr
Capital Expenditure ₹264.67 Cr ₹158.51 Cr ₹131.28 Cr ₹32.88 Cr ₹38.23 Cr
Free Cash Flow (computed) -₹199.6 Cr -₹21.07 Cr -₹88.03 Cr ₹119.52 Cr -₹8.87 Cr
Dividends Paid ₹2.77 Cr ₹2.77 Cr ₹2.76 Cr ₹2.75 Cr ₹2.75 Cr
Net Change in Cash ₹31.11 Cr ₹19.03 Cr -₹44.03 Cr ₹32.36 Cr ₹22.27 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹684.86 Cr ₹581.68 Cr ₹586.11 Cr ₹543.72 Cr ₹579.56 Cr ₹512.73 Cr ₹498.35 Cr ₹489.65 Cr ₹472.72 Cr ₹463.77 Cr ₹483.47 Cr ₹410.61 Cr
Other Income ₹19.07 Cr ₹50.9 Lakh ₹1.6 Cr ₹1.2 Cr ₹1.79 Cr ₹55.1 Lakh ₹71.9 Lakh ₹94.8 Lakh ₹39 Lakh ₹3.5 Cr ₹1.36 Cr ₹2.19 Cr
Total Income ₹703.93 Cr ₹582.19 Cr ₹587.71 Cr ₹544.92 Cr ₹581.35 Cr ₹513.28 Cr ₹499.07 Cr ₹490.6 Cr ₹473.11 Cr ₹467.27 Cr ₹484.83 Cr ₹412.8 Cr
Cost of Materials Consumed ₹444.47 Cr ₹417.6 Cr ₹407.21 Cr ₹334.4 Cr ₹369.77 Cr ₹321.48 Cr ₹324.36 Cr ₹284.03 Cr ₹303.94 Cr ₹291 Cr ₹355.63 Cr ₹272.07 Cr
Purchases of Stock-in-Trade ₹24.1 Cr ₹10.97 Cr ₹29.39 Cr ₹28.96 Cr ₹33.88 Cr ₹45.99 Cr ₹42.34 Cr ₹42.55 Cr ₹38.67 Cr ₹25.3 Cr ₹28.94 Cr ₹41.49 Cr
Changes in Inventories ₹27.16 Cr -₹27.77 Cr -₹35.75 Cr ₹7.99 Cr -₹2.01 Cr -₹17.42 Cr -₹26 Cr ₹14.31 Cr -₹4.34 Cr ₹6.68 Cr -₹41.81 Cr -₹24.05 Cr
Employee Benefit Expense ₹39.23 Cr ₹40.26 Cr ₹37.8 Cr ₹37.47 Cr ₹35.49 Cr ₹35.69 Cr ₹32.56 Cr ₹28.58 Cr ₹25.04 Cr ₹26.04 Cr ₹27.53 Cr ₹24.52 Cr
Finance Costs ₹9.06 Cr ₹7.67 Cr ₹6.09 Cr ₹5.73 Cr ₹5.5 Cr ₹4.94 Cr ₹3.68 Cr ₹3.69 Cr ₹2.52 Cr ₹4.32 Cr ₹5.03 Cr ₹6.32 Cr
Depreciation & Amortisation ₹23.53 Cr ₹19.61 Cr ₹18.23 Cr ₹17.75 Cr ₹18.22 Cr ₹18.32 Cr ₹15.16 Cr ₹15.37 Cr ₹16.07 Cr ₹15.09 Cr ₹15.11 Cr ₹14.11 Cr
Other Expenses ₹72.66 Cr ₹71.75 Cr ₹75.53 Cr ₹67.05 Cr ₹72.93 Cr ₹62.23 Cr ₹59.14 Cr ₹55.28 Cr ₹45.81 Cr ₹51.08 Cr ₹49.61 Cr ₹38.83 Cr
Total Expenses ₹640.2 Cr ₹540.09 Cr ₹538.51 Cr ₹499.34 Cr ₹533.79 Cr ₹471.23 Cr ₹451.25 Cr ₹443.82 Cr ₹427.72 Cr ₹419.51 Cr ₹440.04 Cr ₹373.29 Cr
Profit Before Exceptional Items & Tax ₹63.73 Cr ₹42.1 Cr ₹49.2 Cr ₹45.58 Cr ₹47.56 Cr ₹42.05 Cr ₹47.82 Cr ₹46.78 Cr ₹45.39 Cr ₹47.76 Cr ₹44.79 Cr ₹39.51 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹63.73 Cr ₹42.1 Cr ₹49.2 Cr ₹45.58 Cr ₹47.56 Cr ₹42.05 Cr ₹47.82 Cr ₹46.78 Cr ₹45.39 Cr ₹47.76 Cr ₹44.79 Cr ₹39.51 Cr
Total Tax Expense ₹18.28 Cr ₹9.73 Cr ₹12.8 Cr ₹12.5 Cr ₹13.26 Cr ₹10.68 Cr ₹12.78 Cr ₹12.09 Cr ₹11.44 Cr ₹13.39 Cr ₹11.86 Cr ₹10.24 Cr
Net Profit ₹45.97 Cr ₹32.77 Cr ₹36.88 Cr ₹33.6 Cr ₹34.44 Cr ₹31.7 Cr ₹35.33 Cr ₹34.9 Cr ₹34.13 Cr ₹34.39 Cr ₹32.95 Cr ₹29.22 Cr
  attributable to Owners ₹45.97 Cr ₹32.77 Cr ₹36.88 Cr ₹33.6 Cr ₹34.44 Cr ₹31.7 Cr - - ₹34.13 Cr ₹34.39 Cr ₹32.95 Cr ₹29.22 Cr
  attributable to NCI ₹0 ₹0 ₹0 ₹0 ₹0 - - - ₹0 ₹0 ₹0 -
Other Comprehensive Income ₹62 Lakh -₹17.4 Lakh -₹26.4 Lakh -₹10.6 Lakh -₹1.12 Cr ₹9.3 Lakh ₹30,000 ₹20,000 -₹24.4 Lakh ₹8.5 Lakh ₹8.3 Lakh ₹8.5 Lakh
Total Comprehensive Income ₹46.59 Cr ₹32.6 Cr ₹36.61 Cr ₹33.49 Cr ₹33.32 Cr ₹31.8 Cr ₹35.34 Cr ₹34.9 Cr ₹33.89 Cr ₹34.48 Cr ₹33.03 Cr ₹29.3 Cr
EBITDA (computed) ₹96.32 Cr ₹69.38 Cr ₹73.53 Cr ₹69.06 Cr ₹71.28 Cr ₹65.31 Cr ₹66.66 Cr ₹65.83 Cr ₹63.98 Cr ₹67.17 Cr ₹64.93 Cr ₹59.94 Cr
Basic EPS ₹8.30 ₹5.92 ₹6.66 ₹6.07 ₹6.22 ₹5.73 ₹6.39 ₹6.32 ₹6.18 ₹6.23 ₹5.97 ₹5.30
Diluted EPS ₹8.29 ₹5.91 ₹6.65 ₹6.06 ₹6.21 ₹5.72 ₹6.38 ₹6.30 ₹6.17 ₹6.21 ₹5.95 ₹5.28
Latest 12 quarters shown of 24 on record.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue from Operations ₹1,752.07 Cr ₹1,431.63 Cr ₹1,202.91 Cr ₹975.17 Cr ₹1,072.84 Cr ₹690.41 Cr
Other Income ₹27.01 Cr ₹5.74 Cr ₹6.77 Cr ₹3.6 Cr ₹12.7 Cr ₹10.21 Cr
Total Income ₹1,779.08 Cr ₹1,437.37 Cr ₹1,209.68 Cr ₹978.77 Cr ₹1,085.54 Cr ₹700.62 Cr
Cost of Materials Consumed ₹1,066.43 Cr ₹811.12 Cr ₹625.73 Cr ₹553.96 Cr ₹707.98 Cr ₹433.88 Cr
Purchases of Stock-in-Trade ₹238.46 Cr ₹253 Cr ₹284.99 Cr ₹163.33 Cr ₹122.29 Cr ₹24.99 Cr
Changes in Inventories ₹1.93 Cr -₹17.04 Cr -₹13.58 Cr -₹12.97 Cr -₹10.34 Cr -₹7.22 Cr
Employee Benefit Expense ₹69.46 Cr ₹60.01 Cr ₹51.46 Cr ₹57.35 Cr ₹43.53 Cr ₹36.66 Cr
Finance Costs ₹13.35 Cr ₹9.58 Cr ₹9.7 Cr ₹4.62 Cr ₹2.55 Cr ₹2.99 Cr
Depreciation & Amortisation ₹30.93 Cr ₹27.69 Cr ₹24.19 Cr ₹25.98 Cr ₹26.27 Cr ₹22.07 Cr
Other Expenses ₹167.45 Cr ₹138.31 Cr ₹93.05 Cr ₹90.87 Cr ₹86.59 Cr ₹81.26 Cr
Total Expenses ₹1,588.01 Cr ₹1,282.67 Cr ₹1,075.55 Cr ₹883.13 Cr ₹978.86 Cr ₹594.63 Cr
Profit Before Exceptional Items & Tax ₹191.06 Cr ₹154.7 Cr ₹134.13 Cr ₹95.65 Cr ₹106.68 Cr ₹106 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹191.06 Cr ₹154.7 Cr ₹134.13 Cr ₹95.65 Cr ₹106.68 Cr ₹106 Cr
Total Tax Expense ₹48.22 Cr ₹39.96 Cr ₹34.49 Cr ₹24.26 Cr ₹27.21 Cr ₹26.9 Cr
Net Profit ₹142.84 Cr ₹114.74 Cr ₹99.65 Cr ₹71.39 Cr ₹79.47 Cr ₹79.1 Cr
Other Comprehensive Income -₹5 Lakh -₹28.1 Lakh -₹1.2 Lakh ₹33.7 Lakh ₹1.4 Lakh ₹12.5 Lakh
Total Comprehensive Income ₹142.79 Cr ₹114.46 Cr ₹99.63 Cr ₹71.73 Cr ₹79.49 Cr ₹79.23 Cr
EBITDA (computed) ₹235.34 Cr ₹191.98 Cr ₹168.03 Cr ₹126.25 Cr ₹135.49 Cr ₹131.06 Cr
Basic EPS ₹25.79 ₹20.75 ₹18.05 ₹12.95 ₹14.49 ₹15.34
Diluted EPS ₹25.78 ₹20.72 ₹18.01 ₹12.90 ₹14.40 ₹15.25
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹1,763.64 Cr ₹1,450.92 Cr ₹1,281.17 Cr ₹1,125.67 Cr
Non-current Assets ₹860.64 Cr ₹752.76 Cr ₹713.19 Cr ₹655 Cr
Current Assets ₹903 Cr ₹696.95 Cr ₹566.77 Cr ₹470.67 Cr
Property, Plant & Equipment ₹211.17 Cr ₹170.99 Cr ₹160.19 Cr ₹151.62 Cr
Inventories ₹179.73 Cr ₹178.83 Cr ₹151.13 Cr ₹112.83 Cr
Trade Receivables ₹518.43 Cr ₹374.6 Cr ₹301.91 Cr ₹243.85 Cr
Cash & Equivalents ₹48.65 Cr ₹12.91 Cr ₹22.55 Cr ₹41.02 Cr
Equity (Net Worth) ₹1,218.49 Cr ₹1,077.17 Cr ₹960.34 Cr ₹858.7 Cr
Equity Share Capital ₹11.08 Cr ₹11.07 Cr ₹11.05 Cr ₹11.03 Cr
Borrowings (Non-current) ₹5.12 Cr ₹0 ₹24.94 Cr ₹34.93 Cr
Borrowings (Current) ₹121.39 Cr ₹30.14 Cr ₹30.11 Cr ₹29.98 Cr
Total Debt (computed) ₹126.51 Cr ₹30.14 Cr ₹55.05 Cr ₹64.92 Cr
Current Liabilities ₹521.19 Cr ₹354.32 Cr ₹283.14 Cr ₹229.91 Cr
Total Liabilities ₹545.14 Cr ₹373.75 Cr ₹320.83 Cr ₹266.97 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹58.73 Cr ₹92.2 Cr ₹73.92 Cr ₹113.66 Cr ₹33.12 Cr
Investing Cash Flow -₹101.4 Cr -₹69.92 Cr -₹69.55 Cr -₹160.59 Cr -₹318.12 Cr
Financing Cash Flow ₹79.13 Cr -₹32.27 Cr -₹22.09 Cr ₹61.21 Cr ₹296.91 Cr
Capital Expenditure ₹118.74 Cr ₹52.97 Cr ₹51.83 Cr ₹21.46 Cr ₹32.46 Cr
Free Cash Flow (computed) -₹60.01 Cr ₹39.23 Cr ₹22.09 Cr ₹92.2 Cr ₹65.8 Lakh
Dividends Paid ₹2.77 Cr ₹2.77 Cr ₹2.76 Cr ₹2.75 Cr ₹2.75 Cr
Net Change in Cash ₹35.74 Cr -₹9.64 Cr -₹17.95 Cr ₹14.28 Cr ₹11.91 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹516.14 Cr ₹450.66 Cr ₹419.51 Cr ₹365.76 Cr ₹426.65 Cr ₹368.28 Cr ₹335.99 Cr ₹300.71 Cr ₹313.8 Cr ₹298.75 Cr ₹332.01 Cr ₹258.34 Cr
Other Income ₹22.73 Cr ₹1.14 Cr ₹1.4 Cr ₹1.74 Cr ₹2.4 Cr ₹1.01 Cr ₹1.08 Cr ₹1.26 Cr ₹1.34 Cr ₹2.13 Cr ₹1.96 Cr ₹1.34 Cr
Total Income ₹538.87 Cr ₹451.8 Cr ₹420.91 Cr ₹367.5 Cr ₹429.05 Cr ₹369.28 Cr ₹337.07 Cr ₹301.97 Cr ₹315.15 Cr ₹300.88 Cr ₹333.98 Cr ₹259.68 Cr
Cost of Materials Consumed ₹328.89 Cr ₹274.93 Cr ₹250.87 Cr ₹211.74 Cr ₹258.67 Cr ₹209.81 Cr ₹212.66 Cr ₹129.98 Cr ₹167.53 Cr ₹150.93 Cr ₹186.89 Cr ₹120.39 Cr
Purchases of Stock-in-Trade ₹58.04 Cr ₹58.55 Cr ₹71.79 Cr ₹50.08 Cr ₹61.82 Cr ₹57.74 Cr ₹49.4 Cr ₹84.04 Cr ₹69.89 Cr ₹54.3 Cr ₹82.14 Cr ₹78.66 Cr
Changes in Inventories ₹4.25 Cr ₹2.55 Cr -₹14.21 Cr ₹9.34 Cr -₹4.68 Cr -₹1.31 Cr -₹15.51 Cr ₹4.45 Cr ₹2.45 Cr ₹11.09 Cr -₹17.44 Cr -₹9.68 Cr
Employee Benefit Expense ₹17.75 Cr ₹18.73 Cr ₹17.31 Cr ₹15.67 Cr ₹15.76 Cr ₹16.36 Cr ₹13.57 Cr ₹14.32 Cr ₹11.38 Cr ₹14.06 Cr ₹12.58 Cr ₹13.43 Cr
Finance Costs ₹3.81 Cr ₹3.95 Cr ₹2.49 Cr ₹3.09 Cr ₹3.08 Cr ₹2.28 Cr ₹1.9 Cr ₹2.33 Cr ₹1.74 Cr ₹2.63 Cr ₹2.54 Cr ₹1.88 Cr
Depreciation & Amortisation ₹8.97 Cr ₹7.47 Cr ₹7.34 Cr ₹7.15 Cr ₹7.66 Cr ₹7.43 Cr ₹6.54 Cr ₹6.06 Cr ₹6.58 Cr ₹5.84 Cr ₹6.26 Cr ₹5.51 Cr
Other Expenses ₹43.6 Cr ₹45.53 Cr ₹43.34 Cr ₹34.98 Cr ₹42.88 Cr ₹35.72 Cr ₹31.6 Cr ₹28.11 Cr ₹20.83 Cr ₹27.23 Cr ₹25.5 Cr ₹20.41 Cr
Total Expenses ₹465.32 Cr ₹411.7 Cr ₹378.94 Cr ₹332.06 Cr ₹385.19 Cr ₹328.02 Cr ₹300.16 Cr ₹269.3 Cr ₹280.4 Cr ₹266.08 Cr ₹298.48 Cr ₹230.59 Cr
Profit Before Exceptional Items & Tax ₹73.55 Cr ₹40.1 Cr ₹41.97 Cr ₹35.44 Cr ₹43.86 Cr ₹41.26 Cr ₹36.91 Cr ₹32.67 Cr ₹34.75 Cr ₹34.8 Cr ₹35.5 Cr ₹29.09 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹73.55 Cr ₹40.1 Cr ₹41.97 Cr ₹35.44 Cr ₹43.86 Cr ₹41.26 Cr ₹36.91 Cr ₹32.67 Cr ₹34.75 Cr ₹34.8 Cr ₹35.5 Cr ₹29.09 Cr
Total Tax Expense ₹18.82 Cr ₹9.47 Cr ₹10.72 Cr ₹9.21 Cr ₹11.49 Cr ₹10.63 Cr ₹9.49 Cr ₹8.34 Cr ₹8.58 Cr ₹9.26 Cr ₹9.12 Cr ₹7.53 Cr
Net Profit ₹54.73 Cr ₹30.63 Cr ₹31.25 Cr ₹26.23 Cr ₹32.36 Cr ₹30.63 Cr ₹27.42 Cr ₹24.33 Cr ₹26.17 Cr ₹25.54 Cr ₹26.38 Cr ₹21.56 Cr
Other Comprehensive Income ₹16.1 Lakh -₹7.1 Lakh -₹7 Lakh -₹7 Lakh -₹27.2 Lakh -₹30,000 -₹30,000 -₹30,000 -₹29 Lakh ₹9.2 Lakh ₹9.3 Lakh ₹9.3 Lakh
Total Comprehensive Income ₹54.89 Cr ₹30.56 Cr ₹31.18 Cr ₹26.16 Cr ₹32.09 Cr ₹30.63 Cr ₹27.42 Cr ₹24.33 Cr ₹25.88 Cr ₹25.63 Cr ₹26.47 Cr ₹21.65 Cr
EBITDA (computed) ₹86.33 Cr ₹51.52 Cr ₹51.81 Cr ₹45.69 Cr ₹54.6 Cr ₹50.97 Cr ₹45.35 Cr ₹41.06 Cr ₹43.06 Cr ₹43.27 Cr ₹44.3 Cr ₹36.47 Cr
Basic EPS ₹9.88 ₹5.53 ₹5.64 ₹4.74 ₹5.85 ₹5.53 ₹4.96 ₹4.40 ₹4.74 ₹4.62 ₹4.78 ₹3.91
Diluted EPS ₹9.88 ₹5.53 ₹5.64 ₹4.73 ₹5.84 ₹5.53 ₹4.95 ₹4.40 ₹4.73 ₹4.61 ₹4.77 ₹3.90
Latest 12 quarters shown of 24 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Rossari Biotech Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Rossari Biotech Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 68.15%, foreign institutional investors hold 2.18%, domestic institutional investors hold 18.20%, retail and other public shareholders hold 11.46% of Rossari Biotech Limited. The company had 86,972 shareholders on record.

Promoters: 68.15%DII (Domestic Institutional): 18.20%FII (Foreign Institutional): 2.18%Retail & Others: 11.46%
Mar 2026
QUARTER
68.15% Promoters
18.20% DII (Domestic Institutional)
2.18% FII (Foreign Institutional)
11.46% Retail & Others
Promoter holding - history
Now 68.15% · Mar 2026High 72.69% · Sep 2020Low 68.15% · Mar 2026
67%68.8%70.5%72.3%74%Jul 2020Sep 2021Mar 2023Sep 2024Mar 2026Jul 2020: 72.68%Sep 2020: 72.69%Dec 2020: 72.69%Mar 2021: 72.69%Apr 2021: 68.70%Jun 2021: 68.70%Sep 2021: 68.56%Dec 2021: 68.56%Mar 2022: 68.56%Jun 2022: 68.56%Sep 2022: 68.46%Dec 2022: 68.44%Mar 2023: 68.43%Jun 2023: 68.43%Sep 2023: 68.35%Dec 2023: 68.33%Mar 2024: 68.32%Jun 2024: 68.32%Sep 2024: 68.27%Dec 2024: 68.19%Mar 2025: 68.18%Jun 2025: 68.17%Sep 2025: 68.17%Dec 2025: 68.16%Mar 2026: 68.15%72.69%68.15%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters68.15%68.16%68.17%68.17%68.18%68.19%
Public31.85%31.84%31.83%31.83%31.82%31.81%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Promoters68.15%68.18%68.32%68.43%68.56%72.69%
Public31.85%31.82%31.68%31.57%31.44%27.31%
Promoter change (YoY, %pts)-0.03-0.14-0.11-0.13-4.13-

Board & Governance of Rossari Biotech Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Rossari Biotech Limited has 6 directors - 4 independent and 2 executive. The board is chaired by Edward Menezes.

DirectorPositionOn board sinceListed boards
Edward Menezes Executive Director · Chairperson 2009-08-10 1
Sunil Srinivasan Chari Executive Director · MD 2009-08-10 1
Aseem Dhru Non-Executive - Independent Director 2019-11-12 3
Aparna Sharma Non-Executive - Independent Director 2023-04-29 2
Esha Padmanabhan Achan Non-Executive - Independent Director 2023-10-21 2
Gurudas Vishwas Aras Non-Executive - Independent Director 2024-10-19 3
Board Committees
CommitteeMembers
Audit Committee Aseem Dhru (Chairperson), Aparna Sharma, Esha Padmanabhan Achan, Gurudas Vishwas Aras
Nomination and remuneration committee Gurudas Vishwas Aras (Chairperson), Aparna Sharma, Esha Padmanabhan Achan
Stakeholders Relationship Committee Aparna Sharma (Chairperson), Gurudas Vishwas Aras, Sunil Srinivasan Chari
Risk Management Committee Sunil Srinivasan Chari (Chairperson), Edward Menezes, Esha Padmanabhan Achan, Mikhail Menezes
Corporate Social Responsibility Committee Edward Menezes (Chairperson), Aparna Sharma, Gurudas Vishwas Aras

Group Structure of Rossari Biotech Limited

Rossari Biotech Limited has 5 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Rossari Biotech Limited's business expansion strategy and organizational complexity.

5
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Unitop Chemicals Private Limited U24110MH1980PTC022967 -
Rossari Consumer Products Private Limited U24110MH1999PTC121848 -
Tristar Intermediates Private Limited U24231GJ1997PTC032927 -
Buzil Rossari Private Limited U24297MH2013PTC251413 -
Romakk Chemicals Private Limited U24299MH2021PTC357112 -

Showing major subsidiaries. Total: 5.

Charges & Borrowings of Rossari Biotech Limited

Open charges
₹275.22 Cr
Satisfied charges
₹110.54 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹81.62 Cr
Axis Bank Limited₹75.00 Cr
Citi Bank N.A.₹50.00 Cr
The Hongkong and Shanghai Banking Corporation Limited₹30.00 Cr
Standard Chartered Bank₹25.00 Cr
Others₹13.60 Cr
Latest charge details
DateLenderAmountStatus
06 Nov 2025 Others ₹89.5 Lakh Open
17 Oct 2025 Others ₹1.2 Cr Open
23 Feb 2023 Standard Chartered Bank ₹25 Cr Open
12 Oct 2022 Citi Bank N.A. ₹50 Cr Open
15 Oct 2019 Axis Bank Limited ₹75 Cr Open

Total charge records: 22 View all charges

Employees and EPFO Compliance at Rossari Biotech Limited

Rossari Biotech Limited has a workforce of 459 employees as of Mar 22, 2024.

Employee count
459
Active EPFO establishments
2
Employee growth
-4.77%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Rossari Biotech Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Rossari Biotech Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Rossari Biotech Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Rossari Biotech Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Rossari Biotech Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Rossari Biotech Limited

MSME Payment Delays by Rossari Biotech Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Rossari Biotech Limited

Subsidiaries & Group Companies of Rossari Biotech Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Rossari Biotech Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Rossari Biotech Limited

MCA Filings & Documents of Rossari Biotech Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Rossari Biotech Limited

Charges
06 Nov 2025
A charge with Others amounted to Rs. 0.90 Cr with Charge ID 101190280 was registered on 06 Nov 2025.
Charges
17 Oct 2025
A charge with Others amounted to Rs. 1.20 Cr with Charge ID 101181094 was registered on 17 Oct 2025.
Charges
15 Oct 2025
A charge registered on 12 Oct 2022 via Charge ID 100623997 with Citi Bank N.A. was fully satisfied on 15 Oct 2025.
Activity
30 Jun 2025
Rossari Biotech Limited last Annual general meeting of members was held on 30 Jun 2025 as per latest MCA records.
Activity
31 Mar 2025
Rossari Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
19 Oct 2024
Gurudas Vishwas Aras was appointed as a Director on 19 Oct 2024 & has been associated with this company since 1 year 8 months.

Recent News on Rossari Biotech Limited

Frequently Asked Questions about Rossari Biotech Limited

Rossari Biotech Limited is an active public limited company in the chemicals and materials sector based in Mumbai, Maharashtra, India. It was incorporated on 10 August 2009 (17+ years old) and is registered under CIN L24100MH2009PLC194818. Listed on BSE: 543213 and NSE: ROSSARI. The company has 459 employees.

Rossari Biotech Limited reported revenue of ₹2,084.3 Cr for FY 2025 (up 13.00% YoY).

The current directors of Rossari Biotech Limited are:

The primary industry of Rossari Biotech Limited is chemicals and materials. The company specifically operates in specialty chemicals. The company is currently active in this sector.

Yes. Rossari Biotech Limited is listed on both BSE (code: 543213) and NSE (symbol: ROSSARI).

Rossari Biotech Limited can be reached at the registered office: Rossari House Golden Oak Lbs Marg Surya Nagar, Opp. Mahindra Showroom Vikhroli West, Mumbai, Maharashtra, India – 400079, or through the website rossari.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available